| Year |
Citation |
Score |
| 2024 |
Schniewind I, Besso MJ, Klicker S, Schwarz FM, Hadiwikarta WW, Richter S, Löck S, Linge A, Krause M, Dubrovska A, Baumann M, Kurth I, Peitzsch C. Epigenetic Targeting to Overcome Radioresistance in Head and Neck Cancer. Cancers. 16. PMID 38398123 DOI: 10.3390/cancers16040730 |
0.362 |
|
| 2024 |
Mehralivand S, Thomas C, Puhr M, Claessens F, van de Merbel AF, Dubrovska A, Jenster G, Bernemann C, Sommer U, Erb HHH. New advances of the androgen receptor in prostate cancer: report from the 1st International Androgen Receptor Symposium. Journal of Translational Medicine. 22: 71. PMID 38238739 DOI: 10.1186/s12967-024-04878-5 |
0.324 |
|
| 2024 |
Gorodetska I, Offermann A, Püschel J, Lukiyanchuk V, Gaete D, Kurzyukova A, Freytag V, Haider MT, Fjeldbo CS, Di Gaetano S, Schwarz FM, Patil S, Borkowetz A, Erb HHH, Baniahmad A, ... ... Dubrovska A, et al. ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcription. Theranostics. 14: 714-737. PMID 38169509 DOI: 10.7150/thno.88057 |
0.865 |
|
| 2023 |
Philchenkov A, Dubrovska A. Cancer stem cells as a therapeutic target: current clinical development and future prospective. Stem Cells (Dayton, Ohio). PMID 38096483 DOI: 10.1093/stmcls/sxad092 |
0.34 |
|
| 2023 |
Xia P, Dubrovska A. CD98 heavy chain as a prognostic biomarker and target for cancer treatment. Frontiers in Oncology. 13: 1251100. PMID 37823053 DOI: 10.3389/fonc.2023.1251100 |
0.437 |
|
| 2023 |
Köseer AS, Di Gaetano S, Arndt C, Bachmann M, Dubrovska A. Immunotargeting of Cancer Stem Cells. Cancers. 15. PMID 36900399 DOI: 10.3390/cancers15051608 |
0.391 |
|
| 2023 |
Klusa D, Lohaus F, Franken A, Baumbach M, Cojoc M, Dowling P, Linge A, Offermann A, Löck S, Hušman D, Rivandi M, Polzer B, Freytag V, Lange T, Neubauer H, ... ... Dubrovska A, et al. Dynamics of CXCR4 positive circulating tumor cells in prostate cancer patients during radiotherapy. International Journal of Cancer. PMID 36733230 DOI: 10.1002/ijc.34457 |
0.831 |
|
| 2022 |
Linke D, Donix L, Peitzsch C, Erb HHH, Dubrovska A, Pfeifer M, Thomas C, Fuessel S, Erdmann K. Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines. International Journal of Molecular Sciences. 24. PMID 36614114 DOI: 10.3390/ijms24010666 |
0.739 |
|
| 2022 |
Meyer F, Engel AM, Krause AK, Wagner T, Poole L, Dubrovska A, Peitzsch C, Rothkamm K, Petersen C, Borgmann K. Efficient DNA Repair Mitigates Replication Stress Resulting in Less Immunogenic Cytosolic DNA in Radioresistant Breast Cancer Stem Cells. Frontiers in Immunology. 13: 765284. PMID 35280989 DOI: 10.3389/fimmu.2022.765284 |
0.696 |
|
| 2022 |
Schniewind I, Hadiwikarta WW, Grajek J, Poleszczuk J, Richter S, Peitzsch M, Müller J, Klusa D, Beyreuther E, Löck S, Lühr A, Frosch S, Groeben C, Sommer U, Krause M, ... Dubrovska A, et al. Cellular plasticity upon proton irradiation determines tumor cell radiosensitivity. Cell Reports. 38: 110422. PMID 35196495 DOI: 10.1016/j.celrep.2022.110422 |
0.828 |
|
| 2022 |
Schwarz FM, Schniewind I, Besso MJ, Lange S, Linge A, Patil SG, Loeck S, Klusa D, Dietrich A, Voss-Boehme A, Nowrouzi A, Krause M, Dubrovska A, Kurth I, Peitzsch C. Plasticity within aldehyde dehydrogenase-positive cells determines prostate cancer radiosensitivity. Molecular Cancer Research : McR. PMID 35135863 DOI: 10.1158/1541-7786.MCR-21-0806 |
0.839 |
|
| 2022 |
Donix L, Erb HHH, Peitzsch C, Dubrovska A, Pfeifer M, Thomas C, Fuessel S, Erdmann K. Acquired resistance to irradiation or docetaxel is not associated with cross-resistance to cisplatin in prostate cancer cell lines. Journal of Cancer Research and Clinical Oncology. PMID 35020044 DOI: 10.1007/s00432-022-03914-5 |
0.731 |
|
| 2021 |
Cable J, Pei D, Reid LM, Wang XW, Bhatia S, Karras P, Melenhorst JJ, Grompe M, Lathia JD, Song E, Kuo CJ, Zhang N, White RM, Ma SK, Ma L, ... ... Dubrovska A, et al. Cancer stem cells: advances in biology and clinical translation-a Keystone Symposia report. Annals of the New York Academy of Sciences. PMID 34850398 DOI: 10.1111/nyas.14719 |
0.464 |
|
| 2021 |
Nathansen J, Meyer F, Müller L, Schmitz M, Borgmann K, Dubrovska A. Beyond the Double-Strand Breaks: The Role of DNA Repair Proteins in Cancer Stem-Cell Regulation. Cancers. 13. PMID 34638302 DOI: 10.3390/cancers13194818 |
0.307 |
|
| 2021 |
Püschel J, Dubrovska A, Gorodetska I. The Multifaceted Role of Aldehyde Dehydrogenases in Prostate Cancer Stem Cells. Cancers. 13. PMID 34572930 DOI: 10.3390/cancers13184703 |
0.867 |
|
| 2021 |
Mukha A, Kahya U, Dubrovska A. Targeting glutamine metabolism and autophagy: the combination for prostate cancer radiosensitization. Autophagy. 1-3. PMID 34486482 DOI: 10.1080/15548627.2021.1962682 |
0.533 |
|
| 2021 |
Mukha A, Kahya U, Linge A, Chen O, Löck S, Lukiyanchuk V, Richter S, Alves TC, Peitzsch M, Telychko V, Skvortsov S, Negro G, Aschenbrenner B, Skvortsova II, Mirtschink P, ... ... Dubrovska A, et al. GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy. Theranostics. 11: 7844-7868. PMID 34335968 DOI: 10.7150/thno.58655 |
0.788 |
|
| 2021 |
Nathansen J, Lukiyanchuk V, Hein L, Stolte MI, Borgmann K, Löck S, Kurth I, Baumann M, Krause M, Linge A, Dubrovska A. Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54L. Oncogene. PMID 34079088 DOI: 10.1038/s41388-021-01842-1 |
0.811 |
|
| 2021 |
Lüttich L, Besso MJ, Heiden S, Koi L, Baumann M, Krause M, Dubrovska A, Linge A, Kurth I, Peitzsch C. Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas. Cancers. 13. PMID 33919702 DOI: 10.3390/cancers13081865 |
0.805 |
|
| 2021 |
Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, Abeliovich H, Abildgaard MH, Abudu YP, Acevedo-Arozena A, Adamopoulos IE, Adeli K, Adolph TE, Adornetto A, Aflaki E, ... ... Dubrovska A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy. 1-382. PMID 33634751 DOI: 10.1080/15548627.2020.1797280 |
0.315 |
|
| 2020 |
Mukha A, Dubrovska A. Metabolic Targeting of Cancer Stem Cells. Frontiers in Oncology. 10: 537930. PMID 33415069 DOI: 10.3389/fonc.2020.537930 |
0.451 |
|
| 2020 |
Peitzsch C, Gorodetska I, Klusa D, Shi Q, Alves TC, Pantel K, Dubrovska A. Metabolic regulation of prostate cancer heterogeneity and plasticity. Seminars in Cancer Biology. PMID 33290846 DOI: 10.1016/j.semcancer.2020.12.002 |
0.842 |
|
| 2020 |
Chen O, Manig F, Lehmann L, Sorour N, Löck S, Yu Z, Dubrovska A, Baumann M, Kessler BM, Stasyk O, Kunz-Schughart LA. Dual role of ER stress in response to metabolic co-targeting and radiosensitivity in head and neck cancer cells. Cellular and Molecular Life Sciences : Cmls. PMID 33230565 DOI: 10.1007/s00018-020-03704-7 |
0.354 |
|
| 2020 |
Le Grand M, Mukha A, Püschel J, Valli E, Kamili A, Vittorio O, Dubrovska A, Kavallaris M. Interplay between MycN and c-Myc regulates radioresistance and cancer stem cell phenotype in neuroblastoma upon glutamine deprivation. Theranostics. 10: 6411-6429. PMID 32483461 DOI: 10.7150/Thno.42602 |
0.482 |
|
| 2020 |
Arndt C, Loureiro LR, Feldmann A, Jureczek J, Bergmann R, Máthé D, Hegedüs N, Berndt N, Koristka S, Mitwasi N, Fasslrinner F, Lamprecht C, Kegler A, Hoffmann A, Bartsch T, ... ... Dubrovska A, et al. UniCAR T cell immunotherapy enables efficient elimination of radioresistant cancer cells. Oncoimmunology. 9: 1743036. PMID 32426176 DOI: 10.1080/2162402X.2020.1743036 |
0.496 |
|
| 2020 |
Friedrich M, Wiedemann K, Reiche K, Puppel SH, Pfeifer G, Zipfel I, Binder S, Köhl U, Müller GA, Engeland K, Aigner A, Füssel S, Fröhner M, Peitzsch C, Dubrovska A, et al. The Role of lncRNAs TAPIR-1 and -2 as Diagnostic Markers and Potential Therapeutic Targets in Prostate Cancer. Cancers. 12. PMID 32365858 DOI: 10.3390/Cancers12051122 |
0.796 |
|
| 2020 |
Terraneo N, Jacob F, Dubrovska A, Grünberg J. Novel Therapeutic Strategies for Ovarian Cancer Stem Cells. Frontiers in Oncology. 10: 319. PMID 32257947 DOI: 10.3389/Fonc.2020.00319 |
0.49 |
|
| 2020 |
Terraneo N, Jacob F, Peitzsch C, Dubrovska A, Krudewig C, Huang YL, Heinzelmann-Schwarz V, Schibli R, Béhé M, Grünberg J. L1 Cell Adhesion Molecule Confers Radioresistance to Ovarian Cancer and Defines a New Cancer Stem Cell Population. Cancers. 12. PMID 31952346 DOI: 10.3390/Cancers12010217 |
0.795 |
|
| 2019 |
Schulz A, Gorodetska I, Behrendt R, Fuessel S, Erdmann K, Foerster S, Datta K, Mayr T, Dubrovska A, Muders MH. Linking NRP2 With EMT and Chemoradioresistance in Bladder Cancer. Frontiers in Oncology. 9: 1461. PMID 32038994 DOI: 10.3389/Fonc.2019.01461 |
0.818 |
|
| 2019 |
Seifert M, Peitzsch C, Gorodetska I, Börner C, Klink B, Dubrovska A. Network-based analysis of prostate cancer cell lines reveals novel marker gene candidates associated with radioresistance and patient relapse. Plos Computational Biology. 15: e1007460. PMID 31682594 DOI: 10.1371/Journal.Pcbi.1007460 |
0.835 |
|
| 2019 |
Cirillo G, Peitzsch C, Vittorio O, Curcio M, Farfalla A, Voli F, Dubrovska A, Iemma F, Kavallaris M, Hampel S. When polymers meet carbon nanostructures: expanding horizons in cancer therapy. Future Medicinal Chemistry. 11: 2205-2231. PMID 31538523 DOI: 10.4155/Fmc-2018-0540 |
0.674 |
|
| 2019 |
Digomann D, Linge A, Dubrovska A. SLC3A2/CD98hc, autophagy and tumor radioresistance: a link confirmed. Autophagy. 1-2. PMID 31276435 DOI: 10.1080/15548627.2019.1639302 |
0.832 |
|
| 2019 |
Schulz A, Meyer F, Dubrovska A, Borgmann K. Cancer Stem Cells and Radioresistance: DNA Repair and Beyond. Cancers. 11. PMID 31234336 DOI: 10.3390/Cancers11060862 |
0.518 |
|
| 2019 |
Gorodetska I, Kozeretska I, Dubrovska A. Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance. Journal of Cancer. 10: 2109-2127. PMID 31205572 DOI: 10.7150/Jca.30410 |
0.833 |
|
| 2019 |
Peitzsch C, Nathansen J, Schniewind SI, Schwarz F, Dubrovska A. Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma: Identification, Characterization and Clinical Implications. Cancers. 11. PMID 31052565 DOI: 10.3390/Cancers11050616 |
0.782 |
|
| 2019 |
Gorodetska I, Lukiyanchuk V, Peitzsch C, Kozeretska I, Dubrovska A. BRCA1 and EZH2 cooperate in regulation of prostate cancer stem cell phenotype. International Journal of Cancer. PMID 30968962 DOI: 10.1002/Ijc.32323 |
0.857 |
|
| 2019 |
Peitzsch C, Kurth I, Ebert N, Dubrovska A, Baumann M. Cancer stem cells in radiation response: current views and future perspectives in radiation oncology. International Journal of Radiation Biology. 1-42. PMID 30897014 DOI: 10.1080/09553002.2019.1589023 |
0.858 |
|
| 2019 |
Digomann D, Kurth I, Tyutyunnykova A, Chen O, Löck S, Gorodetska I, Peitzsch C, Skvortsova I, Negro G, Aschenbrenner B, Eisenhofer G, Richter S, Heiden S, Porrmann J, Klink B, ... ... Dubrovska A, et al. The CD98 heavy chain is a marker and regulator of head and neck squamous cell carcinoma radiosensitivity. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30670494 DOI: 10.1158/1078-0432.Ccr-18-2951 |
0.755 |
|
| 2018 |
Domina EA, Philchenkov A, Dubrovska A. Individual Response to Ionizing Radiation and Personalized Radiotherapy. Critical Reviews in Oncogenesis. 23: 69-92. PMID 29953368 DOI: 10.1615/Critrevoncog.2018026308 |
0.377 |
|
| 2018 |
Skvortsov S, Skvortsova II, Tang DG, Dubrovska A. Prostate Cancer Stem Cells: Current Understanding. Stem Cells (Dayton, Ohio). PMID 29845679 DOI: 10.1002/Stem.2859 |
0.586 |
|
| 2018 |
Ina K, Salminger D, Stephan H, Anger M, Peitzsch C, Baumann M, Dubrovska A. PO-1050: Color Coded HNSCC Tumor Cells for Clonal Tracing of Radioresistance Radiotherapy and Oncology. 127: S589-S590. DOI: 10.1016/S0167-8140(18)31360-4 |
0.714 |
|
| 2018 |
Meyer F, Becker S, Niecke A, Riepen B, Zielinski A, Werner S, Peitzsch C, Hein L, Dubrovska A, Wikmann H, Windhorst S, Goy Y, Parplys A, Petersen C, Rothkamm K, et al. OC-0379: DNA repair and stemness determine the sensitizing effect of CHK1, RAD51 and PARP1 inhibition in TNBC Radiotherapy and Oncology. 127: S193-S194. DOI: 10.1016/S0167-8140(18)30689-3 |
0.671 |
|
| 2018 |
Dubrovska A, Tyutyunnykova A, Chen O, Linge A, Löck S, Telychko V, Richter S, Hein L, Toma M, Zschaeck S, Eisenhofer G, Wirth M, Kunz-Schughart L, Tawk B, Schwager C, et al. OC-0152: Glutamine metabolism as potential biomarker and target for prostate cancer radiosensitization Radiotherapy and Oncology. 127: S76-S77. DOI: 10.1016/S0167-8140(18)30462-6 |
0.825 |
|
| 2017 |
Tyutyunnykova A, Telegeev G, Dubrovska A. The controversial role of phospholipase C epsilon (PLCε) in cancer development and progression. Journal of Cancer. 8: 716-729. PMID 28382133 DOI: 10.7150/Jca.17779 |
0.786 |
|
| 2017 |
Coppes RP, Dubrovska A. Targeting Stem Cells in Radiation Oncology Clinical Oncology. 29: 329-334. PMID 28363465 DOI: 10.1016/J.Clon.2017.03.005 |
0.38 |
|
| 2017 |
Peitzsch C, Tyutyunnykova A, Pantel K, Dubrovska A. Cancer stem cells: the root of tumor recurrence and metastasis. Seminars in Cancer Biology. PMID 28257956 DOI: 10.1016/J.Semcancer.2017.02.011 |
0.845 |
|
| 2017 |
Vittorio O, Curcio M, Cojoc M, Goya GF, Hampel S, Iemma F, Dubrovska A, Cirillo G. Polyphenols delivery by polymeric materials: challenges in cancer treatment. Drug Delivery. 24: 162-180. PMID 28156178 DOI: 10.1080/10717544.2016.1236846 |
0.77 |
|
| 2017 |
Kurth I, Digomann D, Hein L, Linge A, Koi L, Loeck S, Maebert K, Stephan H, Peitzsch C, Krause M, Baumann M, Dubrovska A. PO-0968: The Role of epithelial to mesenchymal transition (EMT) as Biomarker for Radioresistance in HNSCC Radiotherapy and Oncology. 123: S534-S535. DOI: 10.1016/S0167-8140(17)31404-4 |
0.762 |
|
| 2017 |
Peitzsch C, Baumbach M, Cojoc M, Hein L, Kurth I, Baumann M, Krause M, Dubrovska A. OC-0436: Cytokine-dependent regulation of prostate cancer stem cell maintenance in response to irradiation Radiotherapy and Oncology. 123: S229-S230. DOI: 10.1016/S0167-8140(17)30878-2 |
0.838 |
|
| 2017 |
Dubrovska A, Peitzsch C, Tyutyunnykova A, Cojoc M. PV-0373: Epigenetic and metabolic reprogramming as a target for prostate tumor radiosensitization Radiotherapy and Oncology. 123: S201. DOI: 10.1016/S0167-8140(17)30815-0 |
0.806 |
|
| 2016 |
Kunz-Schughart LA, Dubrovska A, Peitzsch C, Ewe A, Aigner A, Schellenburg S, Muders MH, Hampel S, Cirillo G, Iemma F, Tietze R, Alexiou C, Stephan H, Zarschler K, Vittorio O, et al. Nanoparticles for radiooncology: Mission, vision, challenges. Biomaterials. 120: 155-184. PMID 28063356 DOI: 10.1016/J.Biomaterials.2016.12.010 |
0.749 |
|
| 2016 |
Linge A, Lohaus F, Löck S, Nowak A, Gudziol V, Valentini C, von Neubeck C, Jütz M, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rödel C, Grosu AL, ... ... Dubrovska A, et al. HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 27913065 DOI: 10.1016/J.Radonc.2016.11.008 |
0.46 |
|
| 2016 |
Kumar S, Chaudhary AK, Kumar R, O'Malley J, Dubrovska A, Wang X, Yadav N, Goodrich DW, Chandra D. Combination therapy induces unfolded protein response and cytoskeletal rearrangement leading to mitochondrial apoptosis in prostate cancer. Molecular Oncology. PMID 27106131 DOI: 10.1016/J.Molonc.2016.03.007 |
0.502 |
|
| 2016 |
Zscheppang K, Kurth I, Wachtel N, Dubrovska A, Kunz-Schughart LA, Cordes N. Efficacy of Beta1 Integrin and EGFR Targeting in Sphere-Forming Human Head and Neck Cancer Cells. Journal of Cancer. 7: 736-45. PMID 27076856 DOI: 10.7150/Jca.14232 |
0.764 |
|
| 2016 |
Peitzsch C, Cojoc M, Hein L, Kurth I, Mӓbert K, Trautmann F, Klink B, Schrock E, Wirth MP, Krause M, Stakhovsky EA, Telegeev GD, Novotny V, Toma MI, Muders M, ... ... Dubrovska A, et al. An epigenetic reprogramming strategy to re-sensitize radioresistant prostate cancer cells. Cancer Research. PMID 26984757 DOI: 10.1158/0008-5472.Can-15-2116 |
0.847 |
|
| 2016 |
Krause M, Dubrovska A, Linge A, Baumann M. Cancer stem cells: Radioresistance, prediction of radiotherapy outcome and specific targets for combined treatments. Advanced Drug Delivery Reviews. PMID 26877102 DOI: 10.1016/J.Addr.2016.02.002 |
0.518 |
|
| 2016 |
Linge A, Lock S, Gudziol V, Nowak A, Lohaus F, von Neubeck C, Jutz M, Abdollahi A, Debus J, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rodel C, ... ... Dubrovska A, et al. Low CSC marker expression and low hypoxia identify good prognosis subgroups in HPV(-)HNSCC after postoperative radiochemotherapy: a multicenter study of the DKTK-ROG. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26755529 DOI: 10.1158/1078-0432.Ccr-15-1990 |
0.412 |
|
| 2016 |
Tyutyunnykova A, Telegeev G, Dubrovska A. EP-2066: Phospholipase Cε as a biomarker of prostate cancer radioresistance Radiotherapy and Oncology. 119: S975. DOI: 10.1016/S0167-8140(16)33317-5 |
0.826 |
|
| 2016 |
Peitzsch C, Cojoc M, Hein L, Baumann M, Dubrovska A. OC-0134: Irradiation-induced plasticity of the cancer stem cell population in prostate cancer Radiotherapy and Oncology. 119: S60-S61. DOI: 10.1016/S0167-8140(16)31383-4 |
0.847 |
|
| 2016 |
Krause M, Dubrovska A, Baumann M. Overcoming Cancer Radioresistance Factors of radioresistance in prostate cancer Radiotherapy and Oncology. 118: S63. DOI: 10.1016/S0167-8140(16)30128-1 |
0.479 |
|
| 2016 |
Vittorio O, Cojoc M, Curcio M, Spizzirri UG, Hampel S, Nicoletta FP, Iemma F, Dubrovska A, Kavallaris M, Cirillo G. Polyphenol Conjugates by Immobilized Laccase: The Green Synthesis of Dextran-Catechin Macromolecular Chemistry and Physics. 217: 1488-1492. DOI: 10.1002/Macp.201600046 |
0.764 |
|
| 2015 |
Kurth I, Hein L, Mäbert K, Peitzsch C, Koi L, Cojoc M, Kunz-Schughart L, Baumann M, Dubrovska A. Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma. Oncotarget. PMID 26460734 DOI: 10.18632/Oncotarget.5417 |
0.842 |
|
| 2015 |
Kuhlmann JD, Hein L, Kurth I, Wimberger P, Dubrovska A. Targeting cancer stem cells: promises and challenges. Anti-Cancer Agents in Medicinal Chemistry. PMID 26179271 DOI: 10.2174/1871520615666150716104152 |
0.837 |
|
| 2015 |
Castro Nava A, Cojoc M, Peitzsch C, Cirillo G, Kurth I, Fuessel S, Erdmann K, Kunhardt D, Vittorio O, Hampel S, Dubrovska A. Development of novel radiochemotherapy approaches targeting prostate tumor progenitor cells using nanohybrids. International Journal of Cancer. 137: 2492-503. PMID 26059723 DOI: 10.1002/Ijc.29614 |
0.845 |
|
| 2015 |
Cojoc M, Peitzsch C, Kurth I, Trautmann F, Kunz-Schughart LA, Telegeev GD, Stakhovsky EA, Walker JR, Simin K, Lyle S, Fuessel S, Erdmann K, Wirth MP, Krause M, Baumann M, ... Dubrovska A, et al. Aldehyde Dehydrogenase Is Regulated by β-Catenin/TCF and Promotes Radioresistance in Prostate Cancer Progenitor Cells. Cancer Research. 75: 1482-94. PMID 25670168 DOI: 10.1158/0008-5472.Can-14-1924 |
0.855 |
|
| 2015 |
Cojoc M, Mäbert K, Muders MH, Dubrovska A. A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms. Seminars in Cancer Biology. 31: 16-27. PMID 24956577 DOI: 10.1016/J.Semcancer.2014.06.004 |
0.834 |
|
| 2014 |
Masjkur J, Arps-Forker C, Poser SW, Nikolakopoulou P, Toutouna L, Chenna R, Chavakis T, Chatzigeorgiou A, Chen LS, Dubrovska A, Choudhary P, Uphues I, Mark M, Bornstein SR, Androutsellis-Theotokis A. Hes3 is expressed in the adult pancreatic islet and regulates gene expression, cell growth, and insulin release. The Journal of Biological Chemistry. 289: 35503-16. PMID 25371201 DOI: 10.1074/Jbc.M114.590687 |
0.339 |
|
| 2014 |
Dubrovska A. Report on the International Workshop 'Cancer stem cells: the mechanisms of radioresistance and biomarker discovery'. International Journal of Radiation Biology. 90: 607-14. PMID 24844377 DOI: 10.3109/09553002.2014.920968 |
0.43 |
|
| 2014 |
Peitzsch C, Perrin R, Hill RP, Dubrovska A, Kurth I. Hypoxia as a biomarker for radioresistant cancer stem cells. International Journal of Radiation Biology. 90: 636-52. PMID 24844374 DOI: 10.3109/09553002.2014.916841 |
0.847 |
|
| 2014 |
Trautmann F, Cojoc M, Kurth I, Melin N, Bouchez LC, Dubrovska A, Peitzsch C. CXCR4 as biomarker for radioresistant cancer stem cells. International Journal of Radiation Biology. 90: 687-99. PMID 24650104 DOI: 10.3109/09553002.2014.906766 |
0.843 |
|
| 2014 |
Mäbert K, Cojoc M, Peitzsch C, Kurth I, Souchelnytskyi S, Dubrovska A. Cancer biomarker discovery: current status and future perspectives. International Journal of Radiation Biology. 90: 659-77. PMID 24524284 DOI: 10.3109/09553002.2014.892229 |
0.832 |
|
| 2014 |
Economopoulou M, Masjkur J, Raiskup F, Ebermann D, Saha S, Karl MO, Funk R, Jaszai J, Chavakis T, Ehrhart-Bornstein M, Pillunat LE, Kunz-Schughart L, Kurth I, Dubrovska A, Androutsellis-Theotokis A. Expression of the transcription factor Hes3 in the mouse and human ocular surface, and in pterygium. International Journal of Radiation Biology. 90: 700-9. PMID 24512568 DOI: 10.3109/09553002.2014.892228 |
0.701 |
|
| 2014 |
Mäbert K, Kurth I, Hein L, Peitzsch C, Cojoc M, Trautmann F, Lukiyanchuk V, Dubrovska A. EP-1803: Comparative analysis of radiation-induced changes in gene expression and migration potential of HNSCC and PC cells Radiotherapy and Oncology. 111: S290-S291. DOI: 10.1016/S0167-8140(15)31921-6 |
0.779 |
|
| 2014 |
Peitzsch C, Cojoc M, Trautmann F, Dubrovska A. PO-0938: Dynamic nature of radioresistant cancer stem cells Radiotherapy and Oncology. 111: S122-S123. DOI: 10.1016/S0167-8140(15)31056-2 |
0.825 |
|
| 2013 |
Kim CH, Axup JY, Lawson BR, Yun H, Tardif V, Choi SH, Zhou Q, Dubrovska A, Biroc SL, Marsden R, Pinstaff J, Smider VV, Schultz PG. Bispecific small molecule-antibody conjugate targeting prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 110: 17796-801. PMID 24127589 DOI: 10.1073/Pnas.1316026110 |
0.818 |
|
| 2013 |
Cojoc M, Peitzsch C, Trautmann F, Polishchuk L, Telegeev GD, Dubrovska A. Emerging targets in cancer management: role of the CXCL12/CXCR4 axis. Oncotargets and Therapy. 6: 1347-61. PMID 24124379 DOI: 10.2147/Ott.S36109 |
0.846 |
|
| 2013 |
Bütof R, Dubrovska A, Baumann M. Clinical perspectives of cancer stem cell research in radiation oncology. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 108: 388-96. PMID 23830466 DOI: 10.1016/J.Radonc.2013.06.002 |
0.517 |
|
| 2013 |
Peitzsch C, Kurth I, Kunz-Schughart L, Baumann M, Dubrovska A. Discovery of the cancer stem cell related determinants of radioresistance. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 108: 378-87. PMID 23830195 DOI: 10.1016/J.Radonc.2013.06.003 |
0.86 |
|
| 2013 |
Zakharchenko O, Cojoc M, Dubrovska A, Souchelnytskyi S. A role of TGFß1 dependent 14-3-3σ phosphorylation at Ser69 and Ser74 in the regulation of gene transcription, stemness and radioresistance. Plos One. 8: e65163. PMID 23741479 DOI: 10.1371/Journal.Pone.0065163 |
0.809 |
|
| 2013 |
Kim S, Dubrovska A, Salamone RJ, Walker JR, Grandinetti KB, Bonamy GM, Orth AP, Elliott J, Porta DG, Garcia-Echeverria C, Reddy VA. FGFR2 promotes breast tumorigenicity through maintenance of breast tumor-initiating cells. Plos One. 8: e51671. PMID 23300950 DOI: 10.1371/Journal.Pone.0051671 |
0.428 |
|
| 2012 |
Dubrovska A, Abdollahi A, Tinhofer I. [Cancer stem cells and high-throughput screening methods]. Strahlentherapie Und Onkologie : Organ Der Deutschen RöNtgengesellschaft ... [Et Al]. 188: 316-9. PMID 22907581 DOI: 10.1007/S00066-012-0207-Z |
0.425 |
|
| 2012 |
Dubrovska A, Hartung A, Bouchez LC, Walker JR, Reddy VA, Cho CY, Schultz PG. CXCR4 activation maintains a stem cell population in tamoxifen-resistant breast cancer cells through AhR signalling. British Journal of Cancer. 107: 43-52. PMID 22644306 DOI: 10.1038/Bjc.2012.105 |
0.825 |
|
| 2012 |
Kim CH, Axup JY, Dubrovska A, Kazane SA, Hutchins BA, Wold ED, Smider VV, Schultz PG. Synthesis of bispecific antibodies using genetically encoded unnatural amino acids. Journal of the American Chemical Society. 134: 9918-21. PMID 22642368 DOI: 10.1021/Ja303904E |
0.761 |
|
| 2012 |
Dubrovska A, Elliott J, Salamone RJ, Telegeev GD, Stakhovsky AE, Schepotin IB, Yan F, Wang Y, Bouchez LC, Kularatne SA, Watson J, Trussell C, Reddy VA, Cho CY, Schultz PG. CXCR4 expression in prostate cancer progenitor cells. Plos One. 7: e31226. PMID 22359577 DOI: 10.1371/Journal.Pone.0031226 |
0.859 |
|
| 2012 |
Kurth I, Nykytenko A, Baumann M, Dubrovska A. OC-33: Cancer Stem Cell Related Biomarkers of Radioresistance in Head and Neck Squamous Cell Carcinoma Radiotherapy and Oncology. 104: 31. DOI: 10.1016/S0167-8140(15)34587-4 |
0.762 |
|
| 2012 |
Cojoc M, Peitzsch C, Baumann M, Dubrovska A. OC-31: Prostate Cancer Stem Cells in Development of Novel Predictive Biomarkers for Radiotherapy Radiotherapy and Oncology. 104: 30-31. DOI: 10.1016/S0167-8140(15)34585-0 |
0.841 |
|
| 2011 |
Dubrovska A, Kim C, Elliott J, Shen W, Kuo TH, Koo DI, Li C, Tuntland T, Chang J, Groessl T, Wu X, Gorney V, Ramirez-Montagut T, Spiegel DA, Cho CY, et al. A chemically induced vaccine strategy for prostate cancer. Acs Chemical Biology. 6: 1223-31. PMID 21936526 DOI: 10.1021/Cb200222S |
0.785 |
|
| 2010 |
Dubrovska A, Elliott J, Salamone RJ, Kim S, Aimone LJ, Walker JR, Watson J, Sauveur-Michel M, Garcia-Echeverria C, Cho CY, Reddy VA, Schultz PG. Combination therapy targeting both tumor-initiating and differentiated cell populations in prostate carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 5692-702. PMID 21138868 DOI: 10.1158/1078-0432.Ccr-10-1601 |
0.799 |
|
| 2009 |
Dubrovska A, Kim S, Salamone RJ, Walker JR, Maira SM, García-Echeverría C, Schultz PG, Reddy VA. The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proceedings of the National Academy of Sciences of the United States of America. 106: 268-73. PMID 19116269 DOI: 10.1073/Pnas.0810956106 |
0.672 |
|
| 2006 |
Iwahana H, Yakymovych I, Dubrovska A, Hellman U, Souchelnytskyi S. Glycoproteome profiling of transforming growth factor-beta (TGFbeta) signaling: nonglycosylated cell death-inducing DFF-like effector A inhibits TGFbeta1-dependent apoptosis. Proteomics. 6: 6168-80. PMID 17080483 DOI: 10.1002/Pmic.200600384 |
0.339 |
|
| 2006 |
Souchelnytskyi S, Lomnytska M, Dubrovska A, Hellman U, Volodko N. Proteomics success story. Towards early detection of breast and ovarian cancer: plasma proteomics as a tool to find novel markers. Proteomics. 6: 65-8. PMID 17031801 DOI: 10.1002/Pmic.200600462 |
0.32 |
|
| 2006 |
Lomnytska M, Dubrovska A, Hellman U, Volodko N, Souchelnytskyi S. Increased expression of cSHMT, Tbx3 and utrophin in plasma of ovarian and breast cancer patients. International Journal of Cancer. 118: 412-21. PMID 16049973 DOI: 10.1002/Ijc.21332 |
0.361 |
|
| 2005 |
Dubrovska A, Kanamoto T, Lomnytska M, Heldin CH, Volodko N, Souchelnytskyi S. TGFbeta1/Smad3 counteracts BRCA1-dependent repair of DNA damage. Oncogene. 24: 2289-97. PMID 15735739 DOI: 10.1038/Sj.Onc.1208443 |
0.37 |
|
| Show low-probability matches. |